Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy

American Journal on Addictions

Volumn 13, Issue 4, 2004, Pages 333-341

  Schmitz, Joy M ^a,b   Stotts, Angela L ^a   Sayre, Shelly L ^a   DeLaune, Katherine A ^a   Grabowski, John ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Mental Sciences Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COCAINE; NALTREXONE; PLACEBO;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOMES RESEARCH; OUTPATIENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PROPHYLAXIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SELF REPORT; SIDE EFFECT; SKILL; SUBSTANCE ABUSE; TRAINING; TREATMENT OUTCOME; URINALYSIS;

ADOLESCENT; ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; COUNSELING; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PSYCHOTHERAPY; RECURRENCE; TREATMENT OUTCOME;

EID: 4544232072     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/10550490490480982     Document Type: Article

References (36)

1. Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol. 1993;54:199-203.
2. Heil SH, Badger GJ, Higgins ST. Alcohol dependence among cocaine-dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol. 2001;62:14-22.
3. Miller NS, Gold MS, Millman RB. Cocaine: general characteristics, abuse, and addiction. New York State Journal of Medicine. 1989;89:390-395.
4. Schmitz JM, Bordnick PS, Kearney ML, Fuller SM, Breckenridge JK. Treatment outcome of cocaine-alcohol dependent patients. Drug Alcohol Depend. 1997;47:55-61.
5. Brower KJ, Blow FC, Hill EM, Mudd SA. Treatment outcome of alcoholics with and without cocaine disorders. Alcohol Clin Exp Res. 1994;18:734-739.
6. Reid LD, Delconte JD, Nichols ML, Bilsky EJ, Hubbell CL. Tests of opioid deficiency hypotheses of alcoholism. Alcohol. 1991;8:247-257.
7. Hurd YL. Cocaine effects on dopamine and opioid peptide neural systems: implications for human cocaine abuse. NIDA Res Monogr. 1996;163:94-116.
8. Sala M, Braida D, Colombo M, et al. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther. 1995;274:450-457.
9. Boyle AE, Stewart RB, Macenski MJ, Spiga R, Johnson BA, Meisch RA. Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys. Alcohol Clin Exp Res. 1998;22:359-366.
10. Corrigall WA, Coen KM. Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology. 1991;104:167-170.
11. De Vry J, Donselaar I, Van Ree JM. Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol. J Pharmacol Exp Ther. 1989;251:735-740.
12. Ramsey NF, van Ree JM. Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol Biochem Behav. 1991;40:807-810.
13. McCaul ME. Efficacy of natrexone for alcoholics with and without comorbid opiate or cocaine dependence. Alcohol Clin Exp Res. 1996;20:216A-218A.
14. Hersh D, Van Kirk JR, Kranzler HR. Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology (Berl). 1998;139:44-52.
15. OsHn DW, Pettinati HM, Volpicelli JR, Wolf AL, Kampman KM, O'Brien CP. The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat. 1999;16:163-167.
16. American Psychiatric Association. Task Force on DSM-IV Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994; xxvii, 886.
17. Stotts AL, Schmitz JM, Rhoades HM, Grabowski J. Motivational interviewing with cocaine-dependent patients: a pilot study. J Consult Clin Psychol. 2001;69:858-862.
18. Carroll KM. Relapse prevention as a psychosocial treatment: a review of controlled clinical trials. Exp Clin Psychopharmacol. 1996;4:46-54.
19. Schmitz JM, Stotts AL, Rhoades HM, Grabowski J. Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav. 2001;26:167-180.
20. Del Boca FK, Kranzler HR, Brown J, Korner PF. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res. 1996;20:1412-1417.
21. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford Press; 1985.
22. Woody GE, Luborsky L, McLellan AT, et al. Psychotherapy for opiate addicts. Does it help? Arch Gen Psychiatry. 1983;40:639-645.
23. Luborsky L, Woody GE, McLellan AT, O'Brien CP, Rosenzweig J. Can independent judges recognize different psychotherapies? An experience with manual-guided therapies. J Consult Clin Psychol. 1982;50:49-62.
24. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P). Version 2.0 New York: Biometric Research Department; 1995.
25. Wilkins JN. Quantitative urine levels of cocaine and other substances of abuse. NIDA Res Monogr. 1997;175:235-252.
26. Littell RC, Milliken GA, Stroup WW, Wolfinger RS. SAS System for Mixed Models. Cary, NC: SAS Institute Inc.; 1996.
27. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
28. Heinala P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2001;21:287-292.
29. Raynor K, Kong H, Chen Y, et al. Pharmacological characterization of the cloned kappa-, delta-, and mu- opioid receptors. Mol Pharmacol. 1994;45:330-334.
30. Jatlow P, Elsworth JD, Bradberry CW, et al. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 1991;48:1787-1794.
31. Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm R. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995;39:69-71.
32. Miller NS, Millman RB, Keskinen S. Outcome at six and twelve months post inpatient treatment for cocaine and alcohol dependence. Adv Alcohol Subst Abuse. 1990;9:101-120.
33. Walsh DC, Hingson RW, Merrigan DM, et al. A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med. 1991;325:775-782.
34. Carroll KM, Nich C, Ball SA, McCance E, Rounsavile BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713-727.
35. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
36. Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol Alcohol. 2001;36:2-10.